Efficacy of letrozole–clomiphene combination vs letrozole alone for ovulation induction in clomiphene-resistant polycystic ovary syndrome: A randomized controlled trial
- HIT Hospital / HITEC Institute of Medical Sciences / NUMS, Taxila
Abstract
Objective: To evaluate the efficacy of a letrozole–clomiphene citrate combined regimen in comparison to letrozole alone for inducing ovulation among women diagnosed with clomiphene-resistant polycystic ovary syndrome.
Methods: This randomized, parallel-group, single-blinded controlled trial (Reg. No. NCT06813118) was conducted at the Department of Obstetrics and Gynaecology, HIT Hospital, HITEC Institute of Medical Sciences, Taxila, from June 2024 to March 2025. In total, 44 women were randomly allocated in two groups; 42 completed the study (n=21 in each group). Group 1 was given clomiphene citrate (100 mg on cycle days 3, 5, and 7) and letrozole (5 mg on days 4, 6, and 8); group 2 was given letrozole (5 mg once daily from day 3 for 5 days). Follicular monitoring was performed with transvaginal sonography. The ovulation rate was considered the primary outcome measure and secondary outcome measures included the number of dominant follicles, endometrial thickness, along with clinical pregnancy rate.
Results: No statistically significant differences were observed in baseline characteristics between the groups (p>0.05). Ovulation was seen in 18 (85.7%) participants in the combination group when compared with 9 (42.9%) in the letrozole alone group (p=0.009). The combination group had a significantly greater proportion of dominant follicles (85.7% vs. 47.6%, p=0.032) and endometrial thickness >8 mm (85.7% vs. 28.6%, p=0.001). In the combination group, there were 5 (23.8%) clinical pregnancies, whereas no pregnancy was seen in the letrozole-alone group (p=0.048).
Conclusion: The concurrent use of letrozole with clomiphene citrate is more effective than letrozole alone for ovulation induction in clomiphene-resistant polycystic ovary syndrome women: improved ovulation, endometrial response and pregnancy outcomes.
Metrics
Keywords
License
Copyright (c) 2026 Rukhsana Shaheen Afzal, Tahira Jabeen, Nida Khan, Sahar Farooq, Khairun Nisa, Fehmida Shaheen

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.